Skip to main content

Hip Arthroplasty, Total

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Exactech
ExactechFL - Gainesville
1 program
Exactech Hip SystemsN/A1 trial
Active Trials
NCT05849961Recruiting2,946Est. Dec 2036

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
2030
2031
ExactechExactech Hip Systems

Clinical Trials (1)

Total enrollment: 2,946 patients across 1 trials

NCT05849961ExactechExactech Hip Systems

Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

Start: Oct 2023Est. completion: Dec 20362,946 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 2,946 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.